| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 6.06e-10 | 37 | 166 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 7.62e-10 | 38 | 166 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.46e-08 | 38 | 166 | 7 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 7.04e-08 | 14 | 166 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | GTPase activator activity | DOCK1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B IQGAP1 TBC1D3I ARHGAP20 TBC1D3G TBCD TBC1D3K TBC1D3F | 9.24e-08 | 279 | 166 | 14 | GO:0005096 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.45e-06 | 11 | 166 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 2.24e-06 | 4 | 166 | 3 | GO:0004971 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK1 TBC1D3 PSD TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B IQGAP1 TBC1D3I ARHGAP20 TBC1D3G VAV2 TBCD TBC1D3K TBC1D3F | 5.36e-06 | 507 | 166 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK1 TBC1D3 PSD TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B IQGAP1 TBC1D3I ARHGAP20 TBC1D3G VAV2 TBCD TBC1D3K TBC1D3F | 5.36e-06 | 507 | 166 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TNIK ERVK-6 AKT3 SGIP1 NT5C3A TSSK2 DGKD ERVK-7 PFKFB3 ALPK1 ERVK-10 REV3L MYO3A GUCY2C ERVK-8 PIP5K1A AKT2 TSSK1B MAP4K4 EIF2AK2 STK24 PRIMPOL | 1.10e-05 | 938 | 166 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 RAG1 SMARCA5 ERCC3 SGIP1 ERVK-7 ERVK-10 REV3L THAP9 ERVK-8 PRIMPOL | 1.26e-05 | 262 | 166 | 11 | GO:0140097 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.47e-05 | 21 | 166 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 7.08e-05 | 52 | 166 | 5 | GO:0035255 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.46e-04 | 37 | 166 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 2.85e-04 | 152 | 166 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 3.52e-04 | 17 | 166 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | enzyme activator activity | DOCK1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B IQGAP1 PSME3 TBC1D3I ARHGAP20 TBC1D3G TBCD TBC1D3K TBC1D3F | 3.91e-04 | 656 | 166 | 15 | GO:0008047 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.20e-04 | 18 | 166 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 5.73e-04 | 46 | 166 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 5.75e-04 | 81 | 166 | 5 | GO:0035254 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TNIK AKT3 NT5C3A TSSK2 DGKD PFKFB3 ALPK1 MYO3A GUCY2C PIP5K1A AKT2 TSSK1B MAP4K4 EIF2AK2 STK24 | 8.69e-04 | 709 | 166 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | TNIK AKT3 TSSK2 ALPK1 MYO3A AKT2 TSSK1B MAP4K4 EIF2AK2 STK24 | 9.44e-04 | 363 | 166 | 10 | GO:0106310 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ADAMTS19 CD46 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 PLAU ERVK-24 | 9.68e-04 | 430 | 166 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | endonuclease activity | 9.73e-04 | 136 | 166 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.00e-03 | 24 | 166 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ADAMTS19 USP25 CD46 ERVK-7 ERVK-21 ERVK-9 ERVK-10 STAMBP ERVK-8 PAN2 ERVK-19 PLAU ERVK-24 | 1.16e-03 | 654 | 166 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 RPS17 ERVK-7 ERVK-21 ERVK-9 ERVK-10 OGN MRPL35 SHANK2 TLN1 ERVK-8 ERVK-5 ERVK-19 MACROH2A2 ERVK-24 EPB41L2 MYBPC1 | 1.24e-03 | 891 | 166 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | zinc ion binding | MORC1 ERVK-6 RAG1 ESRRB ERVK-7 ERVK-21 ERVK-9 ERVK-10 PHF5A RXRB ZCRB1 ERVK-8 ERVK-5 KMT2A ERVK-19 ERVK-24 PRIMPOL | 1.24e-03 | 891 | 166 | 17 | GO:0008270 |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.43e-03 | 27 | 166 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.59e-03 | 28 | 166 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.86e-03 | 8 | 166 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | PH domain binding | 2.38e-03 | 9 | 166 | 2 | GO:0042731 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 RAG1 SMARCA5 ERCC3 SGIP1 NT5C3A ERVK-7 ERVK-10 REV3L THAP9 ERVK-8 PAN2 PRIMPOL | 2.92e-03 | 645 | 166 | 13 | GO:0140640 |
| GeneOntologyMolecularFunction | beta-2 adrenergic receptor binding | 2.96e-03 | 10 | 166 | 2 | GO:0031698 | |
| GeneOntologyMolecularFunction | nuclease activity | 3.25e-03 | 231 | 166 | 7 | GO:0004518 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B PIP5K1A AKT2 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 6.38e-11 | 109 | 163 | 12 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B PIP5K1A AKT2 GRHL3 TBC1D3I TBC1D3G MAP4K4 TBC1D3K TBC1D3F | 9.16e-09 | 244 | 163 | 14 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B IQGAP1 PIP5K1A AKT2 GRHL3 TBC1D3I TBC1D3G MAP4K4 VAV2 TBC1D3K TBC1D3F | 1.05e-08 | 335 | 163 | 16 | GO:0043087 |
| GeneOntologyBiologicalProcess | DNA integration | 3.54e-08 | 13 | 163 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 9.49e-08 | 48 | 163 | 7 | GO:0000731 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B PIP5K1A AKT2 PSME3 GRHL3 TBC1D3I TBC1D3G MAP4K4 CREB3 TBC1D3K TBC1D3F | 2.29e-06 | 499 | 163 | 16 | GO:0051345 |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 CD46 ERVK-7 ERVK-21 ERVK-9 ERVK-10 NEDD4 HAVCR1 SLC20A2 ERVK-8 ERVK-5 ERVK-19 ERVK-24 EIF2AK2 CREB3 | 4.37e-06 | 464 | 163 | 15 | GO:0016032 |
| GeneOntologyBiologicalProcess | cell-cell fusion | 4.98e-06 | 85 | 163 | 7 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 4.98e-06 | 85 | 163 | 7 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 6.77e-06 | 89 | 163 | 7 | GO:0006949 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | RAG1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B IQGAP1 PIP5K1A AKT2 PSME3 GRHL3 TBC1D3I TBC1D3G MAP4K4 VAV2 CREB3 TBC1D3K TBC1D3F | 6.78e-05 | 878 | 163 | 19 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D SSBP1 TBC1D3C TBC1D3B AXIN2 IQGAP1 FSHR PIP5K1A AKT2 PSME3 GRHL3 TBC1D3I TBC1D3G MAP4K4 CREB3 TBC1D3K TBC1D3F | 1.83e-04 | 1028 | 163 | 20 | GO:0043085 |
| GeneOntologyCellularComponent | dendritic spine | 2.22e-05 | 242 | 164 | 10 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 2.64e-05 | 247 | 164 | 10 | GO:0044309 | |
| GeneOntologyCellularComponent | ruffle membrane | 2.10e-04 | 108 | 164 | 6 | GO:0032587 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.60e-04 | 210 | 164 | 8 | GO:0031256 | |
| GeneOntologyCellularComponent | perisynaptic space | 3.63e-04 | 4 | 164 | 2 | GO:0099544 | |
| GeneOntologyCellularComponent | cell projection membrane | PSD FERMT1 GRIA1 GRIA2 SHANK2 SLC20A2 TLN1 PIP5K1A AKT2 PLCG2 ABCC2 | 6.16e-04 | 431 | 164 | 11 | GO:0031253 |
| Domain | TBC | TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.42e-10 | 49 | 156 | 9 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.08e-10 | 53 | 156 | 9 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 7.19e-10 | 55 | 156 | 9 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 7.19e-10 | 55 | 156 | 9 | PS50086 |
| Domain | Pumilio_RNA-bd | 6.93e-05 | 2 | 156 | 2 | IPR033712 | |
| Domain | NHL | 1.54e-04 | 13 | 156 | 3 | PS51125 | |
| Domain | Rhs_assc_core | 2.07e-04 | 3 | 156 | 2 | IPR022385 | |
| Domain | PUF | 2.07e-04 | 3 | 156 | 2 | PF00806 | |
| Domain | PUM_HD | 2.07e-04 | 3 | 156 | 2 | PS50303 | |
| Domain | PUM-HD | 2.07e-04 | 3 | 156 | 2 | IPR033133 | |
| Domain | SYCP1/2 | 2.07e-04 | 3 | 156 | 2 | IPR024835 | |
| Domain | ANF_lig-bd_rcpt | 2.50e-04 | 37 | 156 | 4 | IPR001828 | |
| Domain | ANF_receptor | 2.50e-04 | 37 | 156 | 4 | PF01094 | |
| Domain | - | 2.64e-04 | 106 | 156 | 6 | 1.10.150.50 | |
| Domain | Peripla_BP_I | 3.07e-04 | 39 | 156 | 4 | IPR028082 | |
| Domain | Tox-GHH_dom | 4.11e-04 | 4 | 156 | 2 | IPR028916 | |
| Domain | Tox-GHH | 4.11e-04 | 4 | 156 | 2 | PF15636 | |
| Domain | PUM | 4.11e-04 | 4 | 156 | 2 | PS50302 | |
| Domain | Pumilio_RNA-bd_rpt | 4.11e-04 | 4 | 156 | 2 | IPR001313 | |
| Domain | Ten_N | 4.11e-04 | 4 | 156 | 2 | IPR009471 | |
| Domain | Ten_N | 4.11e-04 | 4 | 156 | 2 | PF06484 | |
| Domain | TENEURIN_N | 4.11e-04 | 4 | 156 | 2 | PS51361 | |
| Domain | Pumilio | 4.11e-04 | 4 | 156 | 2 | SM00025 | |
| Domain | Lig_chan-Glu_bd | 4.25e-04 | 18 | 156 | 3 | PF10613 | |
| Domain | Glu/Gly-bd | 4.25e-04 | 18 | 156 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 4.25e-04 | 18 | 156 | 3 | SM00918 | |
| Domain | Iontro_rcpt | 4.25e-04 | 18 | 156 | 3 | IPR001320 | |
| Domain | Iono_rcpt_met | 4.25e-04 | 18 | 156 | 3 | IPR001508 | |
| Domain | Lig_chan | 4.25e-04 | 18 | 156 | 3 | PF00060 | |
| Domain | PBPe | 4.25e-04 | 18 | 156 | 3 | SM00079 | |
| Domain | SAM_2 | 4.49e-04 | 43 | 156 | 4 | PF07647 | |
| Domain | SAM/pointed | 4.50e-04 | 117 | 156 | 6 | IPR013761 | |
| Domain | - | AKT3 PSD FERMT1 DGKD NIBAN2 TLN1 AKT2 PLCG2 ARHGAP20 VAV2 EPB41L2 | 4.55e-04 | 391 | 156 | 11 | 2.30.29.30 |
| Domain | PH | 5.59e-04 | 278 | 156 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 5.74e-04 | 279 | 156 | 9 | PS50003 | |
| Domain | PH_domain | 5.89e-04 | 280 | 156 | 9 | IPR001849 | |
| Domain | YD | 6.82e-04 | 5 | 156 | 2 | IPR006530 | |
| Domain | SAM | 8.55e-04 | 88 | 156 | 5 | SM00454 | |
| Domain | zf-CCHC | 8.95e-04 | 23 | 156 | 3 | PF00098 | |
| Domain | PH_dom-like | AKT3 PSD FERMT1 DGKD NIBAN2 TLN1 AKT2 PLCG2 ARHGAP20 VAV2 EPB41L2 | 9.23e-04 | 426 | 156 | 11 | IPR011993 |
| Domain | SAM_DOMAIN | 1.21e-03 | 95 | 156 | 5 | PS50105 | |
| Domain | SAM | 1.32e-03 | 97 | 156 | 5 | IPR001660 | |
| Domain | Pkinase | TNIK AKT3 TSSK2 MYO3A GUCY2C AKT2 TSSK1B MAP4K4 EIF2AK2 STK24 | 1.39e-03 | 381 | 156 | 10 | PF00069 |
| Domain | CAMSAP_CH | 1.42e-03 | 7 | 156 | 2 | PF11971 | |
| Domain | CAMSAP_CH | 1.42e-03 | 7 | 156 | 2 | IPR022613 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K | 1.96e-06 | 99 | 120 | 8 | M46448 |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 8.40e-06 | 16 | 120 | 4 | MM15048 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 1.09e-05 | 17 | 120 | 4 | M5488 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 1.39e-05 | 18 | 120 | 4 | M48098 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 7.53e-05 | 27 | 120 | 4 | M27422 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.01e-04 | 29 | 120 | 4 | MM15028 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 1.15e-04 | 30 | 120 | 4 | MM15170 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.32e-04 | 31 | 120 | 4 | M7223 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 2.99e-04 | 69 | 120 | 5 | MM15540 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 2.99e-04 | 69 | 120 | 5 | M27815 | |
| Pathway | REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY | 3.20e-04 | 70 | 120 | 5 | MM15389 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.43e-23 | 11 | 167 | 10 | 16863688 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 5.13e-10 | 4 | 167 | 4 | 10469592 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 7983737 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-5 ERVK-19 ERVK-24 | 8.19e-10 | 94 | 167 | 9 | 21542922 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SMARCA5 ERCC3 MTHFD1L FERMT1 RPS17 DGKD SSBP1 ZBED5 IQGAP1 ZC3H7A VPS33B FDPS TLN1 PES1 RPF2 NCAPD2 ASPM WDR82 MACROH2A2 PRR14L PSME3 PLCG2 IK PUM1 EIF2AK2 EPB41L2 | 1.75e-09 | 1353 | 167 | 26 | 29467282 |
| Pubmed | 1.85e-09 | 12 | 167 | 5 | 14557543 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.55e-09 | 5 | 167 | 4 | 12629516 | |
| Pubmed | AMPA receptor anchoring at CA1 synapses is determined by N-terminal domain and TARP γ8 interactions. | 1.09e-07 | 3 | 167 | 3 | 34426577 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 15144856 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 12700243 | ||
| Pubmed | Subunit-specific role for the amino-terminal domain of AMPA receptors in synaptic targeting. | 1.09e-07 | 3 | 167 | 3 | 28630296 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 36070750 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 32569783 | ||
| Pubmed | Long-term potentiation reconstituted with an artificial TARP/PSD-95 complex. | 1.09e-07 | 3 | 167 | 3 | 36223737 | |
| Pubmed | Persistent synaptic scaling independent of AMPA receptor subunit composition. | 1.09e-07 | 3 | 167 | 3 | 23864664 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 15145077 | ||
| Pubmed | Synaptic transmission and plasticity require AMPA receptor anchoring via its N-terminal domain. | 1.09e-07 | 3 | 167 | 3 | 28290985 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 26585043 | ||
| Pubmed | Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors. | 1.09e-07 | 3 | 167 | 3 | 14687553 | |
| Pubmed | Synaptic homeostasis requires the membrane-proximal carboxy tail of GluA2. | 1.09e-07 | 3 | 167 | 3 | 29180434 | |
| Pubmed | Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. | 1.09e-07 | 3 | 167 | 3 | 19409270 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 21135237 | ||
| Pubmed | LTP requires a reserve pool of glutamate receptors independent of subunit type. | 1.09e-07 | 3 | 167 | 3 | 23235828 | |
| Pubmed | 2.46e-07 | 12 | 167 | 4 | 11891216 | ||
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 4.33e-07 | 4 | 167 | 3 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 4.33e-07 | 4 | 167 | 3 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 4.33e-07 | 4 | 167 | 3 | 17828255 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 24652293 | ||
| Pubmed | Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. | 4.33e-07 | 4 | 167 | 3 | 10027300 | |
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 4.33e-07 | 4 | 167 | 3 | 12692557 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 12125045 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 23664612 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 30931998 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 29581259 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 12414093 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 10688364 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 26932439 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 31231192 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 17409242 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 4.33e-07 | 4 | 167 | 3 | 12359748 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 31992779 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 14561864 | ||
| Pubmed | Long-term potentiation is independent of the C-tail of the GluA1 AMPA receptor subunit. | 4.33e-07 | 4 | 167 | 3 | 32831170 | |
| Pubmed | Cortactin regulates endo-lysosomal sorting of AMPARs via direct interaction with GluA2 subunit. | 4.33e-07 | 4 | 167 | 3 | 29515177 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 1319477 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 8406013 | ||
| Pubmed | AMPA receptor trafficking and synaptic plasticity require SQSTM1/p62. | 4.33e-07 | 4 | 167 | 3 | 19004011 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 9648857 | ||
| Pubmed | SMARCA5 CUX2 GRIA1 RPS17 GRIA2 GRIA3 PHF5A SFMBT2 IQGAP1 ZC3H7A SHANK2 TNN PES1 UNC5C RPF2 NCAPD2 SYCP1 ASPM KMT2A SPDEF ABCC2 PICK1 MYBPC1 | 4.64e-07 | 1442 | 167 | 23 | 35575683 | |
| Pubmed | PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking. | 8.92e-07 | 16 | 167 | 4 | 16055064 | |
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 12604796 | ||
| Pubmed | Phase Separation-Mediated TARP/MAGUK Complex Condensation and AMPA Receptor Synaptic Transmission. | 1.08e-06 | 5 | 167 | 3 | 31492534 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.08e-06 | 5 | 167 | 3 | 11401426 | |
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 16129400 | ||
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 26855332 | ||
| Pubmed | Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. | 1.08e-06 | 5 | 167 | 3 | 17442925 | |
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 22445342 | ||
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 8471161 | ||
| Pubmed | An Important Role of Pumilio 1 in Regulating the Development of the Mammalian Female Germline. | 1.08e-06 | 5 | 167 | 3 | 27170441 | |
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 9482932 | ||
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 15797551 | ||
| Pubmed | GLT8D2 RGSL1 SGIP1 GRIA1 REEP3 OGN CC2D2B IGSF10 TC2N VPS33B HECW2 SLC35B4 SYCP1 PAN2 SPDEF | 1.26e-06 | 686 | 167 | 15 | 29987050 | |
| Pubmed | 1.49e-06 | 18 | 167 | 4 | 34455539 | ||
| Pubmed | 1.49e-06 | 18 | 167 | 4 | 14730302 | ||
| Pubmed | 1.49e-06 | 18 | 167 | 4 | 18664271 | ||
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 1.58e-06 | 74 | 167 | 6 | 16625196 | |
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 30057205 | ||
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 23918399 | ||
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 28194005 | ||
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 15063128 | ||
| Pubmed | 3.75e-06 | 7 | 167 | 3 | 21368048 | ||
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 3.75e-06 | 7 | 167 | 3 | 33981040 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 3.75e-06 | 7 | 167 | 3 | 9016303 | |
| Pubmed | 3.75e-06 | 7 | 167 | 3 | 17093100 | ||
| Pubmed | 3.75e-06 | 7 | 167 | 3 | 27076426 | ||
| Pubmed | 3.75e-06 | 7 | 167 | 3 | 17634444 | ||
| Pubmed | CKAMP44: a brain-specific protein attenuating short-term synaptic plasticity in the dentate gyrus. | 3.75e-06 | 7 | 167 | 3 | 20185686 | |
| Pubmed | Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. | 3.75e-06 | 7 | 167 | 3 | 10407040 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 3.75e-06 | 7 | 167 | 3 | 9651535 | |
| Pubmed | Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. | 5.98e-06 | 8 | 167 | 3 | 23217150 | |
| Pubmed | 8.94e-06 | 9 | 167 | 3 | 24292102 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 8.94e-06 | 9 | 167 | 3 | 9051806 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 9.49e-06 | 281 | 167 | 9 | 28706196 | |
| Pubmed | 1.06e-05 | 60 | 167 | 5 | 32027825 | ||
| Pubmed | 1.27e-05 | 10 | 167 | 3 | 12970426 | ||
| Pubmed | Loss of SynDIG1 Reduces Excitatory Synapse Maturation But Not Formation In Vivo. | 1.27e-05 | 10 | 167 | 3 | 27800545 | |
| Pubmed | Common variants associated with general and MMR vaccine-related febrile seizures. | 1.27e-05 | 10 | 167 | 3 | 25344690 | |
| Pubmed | SMARCA5 ERCC3 MTHFD1L IQGAP1 ABCB10 VPS33B NCAPD2 PIP5K1A IK PUM1 EPB41L2 TBCD | 1.85e-05 | 560 | 167 | 12 | 35241646 | |
| Pubmed | 2.16e-05 | 173 | 167 | 7 | 36217029 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 20167810 | ||
| Pubmed | Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3. | 2.29e-05 | 2 | 167 | 2 | 27708157 | |
| Pubmed | Peripheral calcium-permeable AMPA receptors regulate chronic inflammatory pain in mice. | 2.29e-05 | 2 | 167 | 2 | 21383497 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 28103481 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 12459267 | ||
| Pubmed | Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins. | 2.29e-05 | 2 | 167 | 2 | 29165587 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 14555717 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 35507203 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 26517885 | ||
| Pubmed | Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3. | 2.29e-05 | 2 | 167 | 2 | 12848940 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 12667987 | ||
| Interaction | GRIA1 interactions | 5.77e-06 | 86 | 161 | 7 | int:GRIA1 | |
| Interaction | EAF1 interactions | 8.85e-06 | 128 | 161 | 8 | int:EAF1 | |
| Interaction | GRIA4 interactions | 1.82e-05 | 41 | 161 | 5 | int:GRIA4 | |
| Interaction | GRIA3 interactions | 2.30e-05 | 43 | 161 | 5 | int:GRIA3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.06e-10 | 149 | 166 | 10 | chr17q12 |
| Cytoband | 17q12 | 3.16e-05 | 99 | 166 | 5 | 17q12 | |
| Cytoband | 2p22-p21 | 3.59e-04 | 8 | 166 | 2 | 2p22-p21 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 5.25e-07 | 4 | 93 | 3 | 1200 | |
| GeneFamily | Sterile alpha motif domain containing | 9.04e-05 | 88 | 93 | 5 | 760 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.81e-04 | 206 | 93 | 6 | 682 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.17e-03 | 50 | 93 | 3 | 1293 | |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_PROJECTION_NEURONS | 3.05e-06 | 147 | 157 | 8 | MM414 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 2.35e-08 | 90 | 158 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_200 | 3.05e-07 | 88 | 158 | 8 | gudmap_developingKidney_e15.5_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.09e-06 | 173 | 158 | 9 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TTC39B TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 1.41e-05 | 242 | 158 | 10 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_200 | 2.15e-05 | 155 | 158 | 8 | gudmap_developingKidney_e15.5_anlage of loop of Henle_200 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D DDIT4L TBC1D3C TBC1D3B PLCG2 TBC1D3G TBC1D3K TBC1D3F | 2.89e-05 | 320 | 158 | 11 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.21e-05 | 213 | 158 | 9 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.21e-05 | 213 | 158 | 9 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TNIK TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 5.02e-05 | 281 | 158 | 10 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TNIK TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 5.02e-05 | 281 | 158 | 10 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | DOCK1 CUX2 DDIT4L GRIA1 DGKD REV3L OGN UNC5C ZCRB1 PLAU ARHGAP20 EPB41L2 | 6.26e-05 | 412 | 158 | 12 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | EGLN3 AKT3 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ZFYVE16 HGSNAT DDIT4L DGKD NLGN1 TBC1D3C TBC1D3B RXRB AXIN2 DIP2A NEO1 AKAP9 TOX3 PAN2 PLAU TBC1D3G CCDC136 TBC1D3K TBC1D3F | 8.32e-05 | 1466 | 158 | 25 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#1_top-relative-expression-ranked_100 | 1.29e-04 | 35 | 158 | 4 | gudmap_developingKidney_e15.5_100_k1 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | EGLN3 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ZFYVE16 DDIT4L DGKD NLGN1 TBC1D3C TBC1D3B RXRB NEO1 TOX3 PAN2 PLAU TBC1D3G CCDC136 TBC1D3K TBC1D3F | 1.47e-04 | 1075 | 158 | 20 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | DOCK1 AKT3 DGKD REV3L SIM2 TENM2 AKAP9 TMEM72 ZCRB1 PLAU EIF2AK2 | 2.19e-04 | 402 | 158 | 11 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_100 | 2.55e-04 | 17 | 158 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#3_top-relative-expression-ranked_200 | 2.91e-04 | 43 | 158 | 4 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200_k3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.30e-08 | 194 | 158 | 9 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-08 | 195 | 158 | 9 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 4.43e-07 | 192 | 158 | 8 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.79e-07 | 194 | 158 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.38e-07 | 197 | 158 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.03e-07 | 200 | 158 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.03e-07 | 200 | 158 | 8 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-06 | 175 | 158 | 7 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.48e-06 | 185 | 158 | 7 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.81e-06 | 187 | 158 | 7 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.81e-06 | 187 | 158 | 7 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.53e-06 | 191 | 158 | 7 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.53e-06 | 191 | 158 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.72e-06 | 192 | 158 | 7 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-06 | 192 | 158 | 7 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.92e-06 | 193 | 158 | 7 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.92e-06 | 193 | 158 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.12e-06 | 194 | 158 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.77e-06 | 197 | 158 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | control-Myeloid-Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.77e-06 | 197 | 158 | 7 | 8819db1550bf14566c6d33d97f7f83419e867ace | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.77e-06 | 197 | 158 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.23e-06 | 199 | 158 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.47e-06 | 200 | 158 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 165 | 158 | 6 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 165 | 158 | 6 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 165 | 158 | 6 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-05 | 172 | 158 | 6 | c6bc78fd63c9479a84ec0552b55c89750cad0fa5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-05 | 172 | 158 | 6 | bfb87a281a9cf6ad45b310bf8104fc0ab382b549 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.48e-05 | 104 | 158 | 5 | b5ca6e589f414e549f4990fe334d4ee54829b298 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.83e-05 | 175 | 158 | 6 | 97616bb5c127284aa9e67bc336dfcf29e137164b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 177 | 158 | 6 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 4.21e-05 | 178 | 158 | 6 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-05 | 178 | 158 | 6 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.34e-05 | 179 | 158 | 6 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.48e-05 | 180 | 158 | 6 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.48e-05 | 180 | 158 | 6 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 4.62e-05 | 181 | 158 | 6 | 56fa77ae31f3b7de6e441a439c33a11353b6573a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 182 | 158 | 6 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.76e-05 | 182 | 158 | 6 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-05 | 183 | 158 | 6 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.06e-05 | 184 | 158 | 6 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-05 | 184 | 158 | 6 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.21e-05 | 185 | 158 | 6 | 1fbdc96da0623c3935ae9d29dcb4ba9c474e5c21 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.21e-05 | 185 | 158 | 6 | b45487daac116e3d3d65ac2b0f81d1bf7d1a1914 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 5.21e-05 | 185 | 158 | 6 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-05 | 186 | 158 | 6 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-05 | 186 | 158 | 6 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 5.53e-05 | 187 | 158 | 6 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.53e-05 | 187 | 158 | 6 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 5.70e-05 | 188 | 158 | 6 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-05 | 189 | 158 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-05 | 189 | 158 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.04e-05 | 190 | 158 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.04e-05 | 190 | 158 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-05 | 190 | 158 | 6 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-05 | 190 | 158 | 6 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-05 | 190 | 158 | 6 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 191 | 158 | 6 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 158 | 6 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.22e-05 | 191 | 158 | 6 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.37e-05 | 118 | 158 | 5 | f76fc6db7368a1e8e5e4f8535fc3dc78afe13b9b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.37e-05 | 118 | 158 | 5 | 0dcac16eea8e7978de370a815da9a0cdd212598e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.37e-05 | 118 | 158 | 5 | 7da3957d102e9f9825fc2609d6d0bd9ca6a3fba4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.37e-05 | 118 | 158 | 5 | c5c6724e0e526d7c2fc8cabff4a112a900ec997f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.40e-05 | 192 | 158 | 6 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-05 | 192 | 158 | 6 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.40e-05 | 192 | 158 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-05 | 192 | 158 | 6 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 193 | 158 | 6 | 5879efb38e6b3bf8c33c9a773632b1d726e3c153 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-05 | 193 | 158 | 6 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.59e-05 | 193 | 158 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 193 | 158 | 6 | 725115a5ce3ef520b3ef469e96b8219b4c723fdd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 193 | 158 | 6 | abd7bcf318a2d895d8811c2ada8bfb4314fca3b1 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.59e-05 | 193 | 158 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_activated|Control / Disease group, lineage and cell class | 6.63e-05 | 119 | 158 | 5 | d7352d0dafbb664619b7a1e3cd07b159fdfec197 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.78e-05 | 194 | 158 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 194 | 158 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 194 | 158 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.78e-05 | 194 | 158 | 6 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 194 | 158 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 194 | 158 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 194 | 158 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.78e-05 | 194 | 158 | 6 | 216cba1a04b1a24b080322bc950e7fa2dade5ff1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.98e-05 | 195 | 158 | 6 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-05 | 195 | 158 | 6 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.98e-05 | 195 | 158 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.98e-05 | 195 | 158 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-05 | 195 | 158 | 6 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.98e-05 | 195 | 158 | 6 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.98e-05 | 195 | 158 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-05 | 196 | 158 | 6 | 1bfc3c85ce9501f52a912e53cbded7de74572b9d | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.18e-05 | 196 | 158 | 6 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.18e-05 | 196 | 158 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-05 | 196 | 158 | 6 | e02301642243df483fd066d978317c113c04692b | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.18e-05 | 196 | 158 | 6 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.38e-05 | 197 | 158 | 6 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-05 | 197 | 158 | 6 | 4ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-05 | 198 | 158 | 6 | 688b0eb5534dde40b8630ab8a3252c816711e02e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-05 | 198 | 158 | 6 | 4448d13511485a44fe7b549e4b8b6ad7637db624 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.59e-05 | 198 | 158 | 6 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| Drug | 3-pyridazinol 1-oxide | 1.21e-06 | 4 | 154 | 3 | CID000574311 | |
| Drug | AC1L1YEG | 3.00e-06 | 5 | 154 | 3 | CID000063114 | |
| Drug | Chicago acid | 3.00e-06 | 5 | 154 | 3 | CID000065740 | |
| Drug | CHEBI:570577 | 3.00e-06 | 5 | 154 | 3 | CID011334126 | |
| Drug | 1-BCP | 3.00e-06 | 5 | 154 | 3 | CID000001370 | |
| Drug | irampanel | 3.00e-06 | 5 | 154 | 3 | CID003038472 | |
| Drug | LY395153 | 3.00e-06 | 5 | 154 | 3 | CID000656707 | |
| Drug | beta-N-oxalylaminoalanine | 3.00e-06 | 5 | 154 | 3 | CID000107978 | |
| Drug | 5-h PCA | 3.00e-06 | 5 | 154 | 3 | CID000129091 | |
| Drug | YM928 | 5.98e-06 | 6 | 154 | 3 | CID006918393 | |
| Drug | 2cmo | 5.98e-06 | 6 | 154 | 3 | CID006914597 | |
| Drug | 4,6-dichloroindole-2-carboxylic acid | 1.04e-05 | 7 | 154 | 3 | CID000127988 | |
| Drug | thio-ATPA | 1.04e-05 | 7 | 154 | 3 | CID005289517 | |
| Drug | homoibotenic acid | 1.66e-05 | 8 | 154 | 3 | CID000194385 | |
| Drug | 1-hydroxypyrazole | 1.66e-05 | 8 | 154 | 3 | CID003016733 | |
| Drug | 1-hydroxyimidazole | 1.66e-05 | 8 | 154 | 3 | CID003614351 | |
| Drug | 2,3-PDCA | 1.66e-05 | 8 | 154 | 3 | CID000127037 | |
| Drug | M100907 | 2.42e-05 | 51 | 154 | 5 | CID000060858 | |
| Drug | 1m5b | 2.47e-05 | 9 | 154 | 3 | CID000447081 | |
| Drug | Ly294486 | 2.47e-05 | 9 | 154 | 3 | CID005311255 | |
| Drug | isothiazol-3-one | 2.47e-05 | 9 | 154 | 3 | CID000096917 | |
| Drug | Benzoates | 3.52e-05 | 10 | 154 | 3 | ctd:D001565 | |
| Drug | 2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid | 4.55e-05 | 2 | 154 | 2 | ctd:C474829 | |
| Drug | 4-bromohomoibotenic acid | 4.55e-05 | 2 | 154 | 2 | ctd:C023366 | |
| Drug | 5-fluorowillardiine | 4.55e-05 | 2 | 154 | 2 | ctd:C095178 | |
| Drug | Measles-Mumps-Rubella Vaccine | 4.55e-05 | 2 | 154 | 2 | ctd:D022542 | |
| Drug | geldanamycin | AKT3 INPP5A USP25 GRIA3 RFX7 IQGAP1 DIP2A ASPM KMT2A PLAU PRR14L | 4.67e-05 | 371 | 154 | 11 | ctd:C001277 |
| Drug | AC1L32TU | 4.81e-05 | 30 | 154 | 4 | CID000107831 | |
| Drug | J-ST | 4.81e-05 | 11 | 154 | 3 | CID005288655 | |
| Drug | YM872 | 4.81e-05 | 11 | 154 | 3 | CID000148200 | |
| Drug | 0-ol | 4.81e-05 | 11 | 154 | 3 | CID000069892 | |
| Drug | sym 2206 | 4.81e-05 | 11 | 154 | 3 | CID005039877 | |
| Drug | Atpa | 6.38e-05 | 12 | 154 | 3 | CID000002252 | |
| Drug | 1NaPP1 | 6.38e-05 | 12 | 154 | 3 | CID000004877 | |
| Drug | C-X6 | 6.38e-05 | 12 | 154 | 3 | CID005288002 | |
| Drug | pafuramidine | 6.38e-05 | 12 | 154 | 3 | ctd:C458513 | |
| Drug | 6,7-dinitroquinoxaline | 7.07e-05 | 33 | 154 | 4 | CID002724608 | |
| Drug | D-CPPene | 7.97e-05 | 34 | 154 | 4 | CID006435801 | |
| Drug | Naspm | 8.26e-05 | 13 | 154 | 3 | CID000129695 | |
| Drug | quinoxaline-2,3-dione | 1.05e-04 | 14 | 154 | 3 | CID011469229 | |
| Drug | thiokynurenic acid | 1.30e-04 | 15 | 154 | 3 | CID003035667 | |
| Drug | nonanol | 1.30e-04 | 15 | 154 | 3 | CID000008914 | |
| Disease | Arsenic Induced Polyneuropathy | 2.46e-08 | 62 | 146 | 7 | C0751852 | |
| Disease | Arsenic Encephalopathy | 2.46e-08 | 62 | 146 | 7 | C0751851 | |
| Disease | Arsenic Poisoning | 2.46e-08 | 62 | 146 | 7 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 2.46e-08 | 62 | 146 | 7 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 2.46e-08 | 62 | 146 | 7 | C0274862 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.00e-06 | 16 | 146 | 4 | DOID:331 (implicated_via_orthology) | |
| Disease | Dermatologic disorders | 2.01e-06 | 75 | 146 | 6 | C0037274 | |
| Disease | hair colour measurement | TNIK CUX2 ZFYVE16 PUM2 REV3L PKD1L3 AXIN2 NEO1 TENM4 TOX3 EPB41L2 TBCD | 5.89e-05 | 615 | 146 | 12 | EFO_0007822 |
| Disease | Febrile seizure (within the age range of 3 months to 6 years), MMR-related febrile seizures | 7.27e-05 | 3 | 146 | 2 | EFO_0006519, HP_0002373 | |
| Disease | C-C motif chemokine 3 measurement | 9.17e-05 | 18 | 146 | 3 | EFO_0008051 | |
| Disease | Bipolar Disorder | 1.39e-04 | 477 | 146 | 10 | C0005586 | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.43e-04 | 100 | 146 | 5 | DOID:1824 (biomarker_via_orthology) | |
| Disease | 7-methylxanthine measurement | 1.45e-04 | 4 | 146 | 2 | EFO_0021176 | |
| Disease | prostate cancer (is_implicated_in) | 2.97e-04 | 117 | 146 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | Psychosexual Disorders | 3.60e-04 | 6 | 146 | 2 | C0033953 | |
| Disease | Hypoactive Sexual Desire Disorder | 3.60e-04 | 6 | 146 | 2 | C0020594 | |
| Disease | Sexual Arousal Disorder | 3.60e-04 | 6 | 146 | 2 | C0036902 | |
| Disease | Frigidity | 3.60e-04 | 6 | 146 | 2 | C0016722 | |
| Disease | Orgasmic Disorder | 3.60e-04 | 6 | 146 | 2 | C0029261 | |
| Disease | myocardial infarction | 3.69e-04 | 350 | 146 | 8 | EFO_0000612 | |
| Disease | Schizophrenia | TNIK PSD INPP5A SREBF2 GRIA1 GRIA2 GRIA3 NLGN1 TENM4 UNC5C ERVK-8 KMT2A PICK1 | 4.62e-04 | 883 | 146 | 13 | C0036341 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 6.38e-04 | 291 | 146 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | triacylglycerol 58:6 measurement | 6.68e-04 | 8 | 146 | 2 | EFO_0010440 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 6.68e-04 | 8 | 146 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | Atypical hemolytic-uremic syndrome | 8.56e-04 | 9 | 146 | 2 | cv:C2931788 | |
| Disease | Hemolytic-uremic syndrome | 8.56e-04 | 9 | 146 | 2 | cv:C0019061 | |
| Disease | coronary artery disease | ANKRD31 TTC39B CUX2 DYNC2H1 MTHFD1L PKD1L3 NEDD4 IGSF10 VPS33B UNC5C PAN2 PLCG2 ARHGAP20 STK24 TBCD | 8.79e-04 | 1194 | 146 | 15 | EFO_0001645 |
| Disease | urate measurement, bone density | NAT1 MTHFD1L INPP5A SLC26A5 DGKD TENM2 THAP9 SFMBT2 GLP2R SLC30A9 | 1.06e-03 | 619 | 146 | 10 | EFO_0003923, EFO_0004531 |
| Disease | Atypical Hemolytic Uremic Syndrome | 1.07e-03 | 10 | 146 | 2 | C2931788 | |
| Disease | high grade glioma (is_marker_for) | 1.18e-03 | 42 | 146 | 3 | DOID:3070 (is_marker_for) | |
| Disease | age-related hearing impairment | 1.19e-03 | 324 | 146 | 7 | EFO_0005782 | |
| Disease | obesity | 1.31e-03 | 241 | 146 | 6 | EFO_0001073 | |
| Disease | diffuse plaque measurement | TTC39B EGLN3 PSMF1 SAMD9 KLC4 TENM4 SHANK2 SPDEF SETD3 EIF2AK2 ANO3 | 1.42e-03 | 758 | 146 | 11 | EFO_0010699 |
| Disease | specific language impairment, dyslexia | 1.55e-03 | 12 | 146 | 2 | EFO_0005424, EFO_1001510 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 1.64e-03 | 47 | 146 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | lifestyle measurement, depressive symptom measurement | 1.87e-03 | 105 | 146 | 4 | EFO_0007006, EFO_0010724 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.08e-03 | 51 | 146 | 3 | cv:CN043650 | |
| Disease | Malformations of Cortical Development | 2.13e-03 | 14 | 146 | 2 | C1955869 | |
| Disease | triacylglycerol 48:4 measurement | 2.13e-03 | 14 | 146 | 2 | EFO_0010407 | |
| Disease | Cortical Dysplasia | 2.13e-03 | 14 | 146 | 2 | C0431380 | |
| Disease | glucose metabolism measurement, age-related hearing impairment | 2.20e-03 | 52 | 146 | 3 | EFO_0005782, EFO_0009367 | |
| Disease | Influenza | 2.20e-03 | 52 | 146 | 3 | C0021400 | |
| Disease | cancer (implicated_via_orthology) | 2.23e-03 | 268 | 146 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | MMR-related febrile seizures | 2.45e-03 | 15 | 146 | 2 | EFO_0006519 | |
| Disease | periprosthetic osteolysis, disease progression measurement | 2.45e-03 | 15 | 146 | 2 | EFO_0008336, EFO_0009761 | |
| Disease | Colorectal Carcinoma | DNAH3 MTHFD1L CD46 AXIN2 AKAP9 ABCB10 GUCY2C PAN2 ABCC2 CDH5 | 2.67e-03 | 702 | 146 | 10 | C0009402 |
| Disease | Chromosome Aberrations | 2.79e-03 | 16 | 146 | 2 | C0008625 | |
| Disease | Autosome Abnormalities | 2.79e-03 | 16 | 146 | 2 | C0004403 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 2.79e-03 | 16 | 146 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Alzheimer disease | 2.94e-03 | 485 | 146 | 8 | MONDO_0004975 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.15e-03 | 17 | 146 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | polycystic ovary syndrome | 3.30e-03 | 60 | 146 | 3 | EFO_0000660 | |
| Disease | response to antipsychotic drug | 3.30e-03 | 60 | 146 | 3 | GO_0097332 | |
| Disease | uric acid measurement | 3.44e-03 | 610 | 146 | 9 | EFO_0004761 | |
| Disease | urolithiasis | 3.79e-03 | 63 | 146 | 3 | MONDO_0024647 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 3.93e-03 | 19 | 146 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | blood arsenic measurement | 3.93e-03 | 19 | 146 | 2 | EFO_0021527 | |
| Disease | susceptibility to vaginal yeast infection measurement | 4.14e-03 | 65 | 146 | 3 | EFO_0008412 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 4.32e-03 | 66 | 146 | 3 | EFO_0007708 | |
| Disease | CCL4 measurement | 4.36e-03 | 20 | 146 | 2 | EFO_0004751 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 4.36e-03 | 20 | 146 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | platelet component distribution width | 4.45e-03 | 755 | 146 | 10 | EFO_0007984 | |
| Disease | Grand Mal Status Epilepticus | 4.51e-03 | 67 | 146 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 4.51e-03 | 67 | 146 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 4.51e-03 | 67 | 146 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 4.51e-03 | 67 | 146 | 3 | C0751523 | |
| Disease | Petit mal status | 4.51e-03 | 67 | 146 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 4.51e-03 | 67 | 146 | 3 | C0393734 | |
| Disease | Seizures | 4.67e-03 | 218 | 146 | 5 | C0036572 | |
| Disease | Status Epilepticus | 4.70e-03 | 68 | 146 | 3 | C0038220 | |
| Disease | hepatitis B (is_marker_for) | 4.80e-03 | 21 | 146 | 2 | DOID:2043 (is_marker_for) | |
| Disease | risk-taking behaviour | 4.83e-03 | 764 | 146 | 10 | EFO_0008579 | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.90e-03 | 69 | 146 | 3 | DOID:1682 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KAARVIIEKYYTRLG | 11 | P08708 | |
| LAQYIFTLKRKTGRK | 31 | Q9H0P0 | |
| EKATGRYYAMKILRK | 171 | P31751 | |
| YLERIGYKKSRNKLD | 6 | P18440 | |
| LEDSKYRKIYSFTLK | 181 | P18440 | |
| VTLKRIYGKYLRAES | 3696 | Q99996 | |
| VTGKTRTKEKYRVVY | 166 | O14627 | |
| YLKKGTFKYRISVGA | 31 | Q9P0M6 | |
| GLTYYLVRFKGSKKD | 566 | Q9BQL6 | |
| IYGRYLRKLTKVTQD | 331 | Q9NRK6 | |
| KTLRVAKAIYKRYIE | 126 | Q9Y2T1 | |
| SSGFRLVKKKLYSLI | 171 | Q96D03 | |
| EKKAYLKRRYGLIST | 1126 | O14529 | |
| YGKSKAKVRLSVLER | 391 | Q6UB35 | |
| LKTIYRKAVKYDLGS | 261 | Q6DHV5 | |
| KYLLKGEYVGKVFRV | 81 | P33151 | |
| GSRLGKYYVKERSKA | 106 | Q9H6Z9 | |
| LYKRRKESILTIQKY | 1506 | Q8IZT6 | |
| KVILVREKASGKYYA | 161 | Q9Y243 | |
| IVYLGDYLTVKKKGR | 1031 | Q96QP1 | |
| LFKDGKKRIDYILVY | 156 | Q9BYT9 | |
| KKRIDYILVYRKTNI | 161 | Q9BYT9 | |
| SLKKIYDREQTRYKA | 91 | P46940 | |
| ELLSTKFKYRYEGKI | 921 | P15918 | |
| RKIAESGRGKRYSYK | 306 | Q8TE59 | |
| KPRRVASYKKGTLEY | 1046 | P25092 | |
| LRKYTYGKHILAKLE | 1031 | Q8TB72 | |
| VLKKYDYDSSSVRKR | 476 | Q96TA1 | |
| IYFGRSKKRLSTLKF | 81 | Q86VD1 | |
| SKVTYLGKELLRYVS | 1766 | Q8N7Z5 | |
| KLRNFYRKLETKGYG | 1196 | Q9P2P5 | |
| LAVLYGKRGKYKEAE | 301 | Q9NSK0 | |
| LKRDGRYIYYLITKK | 71 | Q9Y530 | |
| YRKVTIKYSKLGLED | 491 | Q504Q3 | |
| TISGKKDKLRVYYLS | 981 | O95819 | |
| YRYLQRRKKKGTYLT | 366 | P15529 | |
| KSRVKGYLRLKMTYL | 556 | P46934 | |
| LVRFTEKRYKSIVKY | 251 | P14324 | |
| RYRIYSVKDGKNGKS | 241 | Q53G44 | |
| LKISYKRSNFYIKVR | 446 | O43491 | |
| VARVRKSKGKYAYLL | 711 | P42262 | |
| VRIKYKLSIVGDGKY | 466 | P42263 | |
| KYRKVAGKEIYSDTL | 126 | Q14642 | |
| RGKTYISKKLTRYLN | 46 | Q16875 | |
| RKKFKYDGEIRVLYS | 696 | O15117 | |
| LYIYKDREVTKKLVR | 131 | Q9UJM8 | |
| SAYLYARFNKIKKLT | 121 | P20774 | |
| YLDYRKKAIKDLGIS | 206 | Q9H1C3 | |
| YKKALTLSNLARKEY | 401 | Q92887 | |
| QRTVKALYDYKAKRS | 771 | P16885 | |
| ILAFAALYYKKDKRR | 731 | Q8N2Q7 | |
| IKYDLKGSTYKRRAS | 256 | Q99755 | |
| TSIALKYYKDRGQIR | 191 | Q8NBF2 | |
| LRKYTYGKHILAKLE | 1151 | Q14671 | |
| KYASYLSFIKILLKR | 11 | P87889 | |
| KYASYLSFIKILLKR | 11 | Q9YNA8 | |
| KYASYLSFIKILLKR | 11 | P62683 | |
| KYASYLSFIKILLKR | 11 | P63145 | |
| KYASYLSFIKILLKR | 11 | Q9HDB9 | |
| KYASYLSFIKILLKR | 11 | Q7LDI9 | |
| KYASYLSFIKILLKR | 11 | P63130 | |
| KYASYLSFIKILLKR | 11 | P62685 | |
| KYASYLSFIKILLKR | 11 | P63126 | |
| KYASYLSFIKILLKR | 11 | P62684 | |
| YDSTRGRLATYVLKK | 2231 | Q8NCM8 | |
| KLKGRSDRKYYAKTG | 281 | Q02985 | |
| KVRKLQKDTFYGLRS | 116 | Q6WRI0 | |
| FRDYKYRLAKSTLVL | 376 | O95838 | |
| YKVYKKCKRGETSLL | 556 | Q8TE85 | |
| YRGYTLRKKSKKGIF | 46 | Q14185 | |
| YRSELKAIRLGQKSY | 3456 | Q9UFH2 | |
| SVKKLSLDYYNKLRR | 2631 | Q8TD57 | |
| HRIDGKTYVIKRVKY | 286 | P19525 | |
| IREKYKASKYLCVSL | 441 | P78396 | |
| KLRGRTLYYAKTAKS | 76 | Q16760 | |
| YFSSAKYAKEGLIRK | 631 | Q03164 | |
| QAGKILLYYKARTKD | 516 | Q68CP4 | |
| EYVAIKTKKRILLYT | 521 | P19447 | |
| KGYEKKRAKLLARYI | 36 | Q14689 | |
| YRAILQLVRRYKKLK | 321 | O95718 | |
| YGLENLKKLRARSTY | 236 | P23945 | |
| RVRKSKGKYAYLLES | 706 | P42261 | |
| KKVYVGGLESRVLKY | 171 | O43889 | |
| RGKLSLSDKFRKEYY | 446 | Q9P1V8 | |
| LVGDTVSYSKKRLRY | 416 | Q08357 | |
| RLYKSSKIGKRVALE | 291 | Q96LW4 | |
| VLRYEYKDGSRKLLV | 66 | Q92530 | |
| YKRLRYKRLLDGFSS | 1651 | Q5THK1 | |
| LRYGFTKEILHKYKL | 241 | O14829 | |
| KLTYLRGIYSKKQHK | 856 | Q9P2F6 | |
| RSYLQYRGKKFKDRK | 986 | A5PLK6 | |
| KKEDYIVYLGRSRLN | 231 | P00749 | |
| ILKKRYSIFKYTSIA | 111 | Q969S0 | |
| RYSTYAALLRVKLKA | 951 | A5PKW4 | |
| FSSGELIYKKKTRLL | 396 | Q8N9U0 | |
| KKTSYLTELIDRYKR | 291 | Q9Y6E0 | |
| KTRRKVAGYFKKYVD | 1291 | Q5K651 | |
| IYSLIDKKKQFRSRG | 116 | Q9H5J8 | |
| LKYLFGVKTKRYSGI | 226 | P58743 | |
| YRKDTRYKLLGDLSR | 71 | Q96D42 | |
| ITGYKIRYRKASRKS | 666 | Q92859 | |
| RISSKGDKCLLKYYF | 121 | Q7Z443 | |
| VRSLTYFSARKGKRK | 91 | Q9NZE8 | |
| VKGQVTTKYYRLLSK | 286 | Q14190 | |
| RVKIKLGVSKSDRLY | 336 | Q86TU7 | |
| RQVFYKYGKLSKLSE | 2016 | Q9NT68 | |
| EKYKSSRKLIDRAYK | 86 | B9A6J9 | |
| TTKGRKEVRYGSLKY | 231 | Q6NUK4 | |
| GKIYFRSYKLLLKKS | 191 | Q9H7B2 | |
| KYASYLSFIKILLKR | 11 | P63128 | |
| KGFFKRTIRKDLTYS | 226 | P28702 | |
| LEFRYKKRVYKQASL | 136 | Q9UPX8 | |
| LYYKASQRKLDGLAK | 1021 | Q96JN2 | |
| VKGRIYQLLAKASYK | 516 | Q15021 | |
| ELEAKQLRRLYKYTK | 121 | Q86WR6 | |
| RYYITRAKLVSKIAK | 181 | P61289 | |
| EKYKSSRKLIDRAYK | 86 | A6NDS4 | |
| EKYKSSRKLIDRAYK | 86 | P0C7X1 | |
| GRLKRKKLLKEYYST | 761 | A0JNW5 | |
| VTISGKKNKLRVYYL | 1101 | Q9UKE5 | |
| IKGGLKIRTSYQIYK | 261 | Q5VTQ0 | |
| KRTLYSKKYGVDLIR | 56 | Q6UXN9 | |
| KKKYERGSATNYITR | 6 | O00541 | |
| RALRKVFLSIKGIYY | 176 | O00541 | |
| GLYGNKYTLRAKRKV | 911 | O60673 | |
| ASSKERYKLTVGKYR | 1181 | Q9UQP3 | |
| LCSSKVYDYVRKILK | 221 | Q9H5L6 | |
| EKYKSSRKLIDRAYK | 86 | A6NER0 | |
| IIFVYYLRKGKKINS | 51 | Q5MJ09 | |
| RFSLIKKRFAAGKYL | 811 | Q9BQI5 | |
| GLSRVYSKLYKEAEK | 101 | Q15431 | |
| VRYVKLARSLKTYGV | 296 | Q9Y490 | |
| SRSIRQYYKKGIIRK | 306 | O95238 | |
| RKDRRIVSKKYKIYF | 431 | Q9NXL6 | |
| YVKKGSRIYLEGKID | 101 | Q04837 | |
| LKAELLKRYTKEYTE | 106 | O95630 | |
| KTIEESLIYRKKYIL | 731 | Q9BX26 | |
| SLIYRKKYILSKDVN | 736 | Q9BX26 | |
| KSGVLRKAIDYIKYL | 366 | Q12772 | |
| QGLRTLYKRLKEYAK | 66 | O95073 | |
| QEETLKAKYRGKTYR | 596 | Q5VUG0 | |
| KAKYRGKTYRAVVKI | 601 | Q5VUG0 | |
| RYLFALLVGTKRKYV | 226 | Q9UHP3 | |
| TGRRVIYKYGKLSKL | 2006 | Q6N022 | |
| AARRRKKKSYYAKLR | 71 | Q13123 | |
| TRGKSKYCYSGLRKK | 71 | Q2KHR2 | |
| AKKEYLKALAAYRAS | 311 | O15405 | |
| LKEIRKTVSGTALYY | 101 | Q8NDW8 | |
| IVEKFTRLLYYGRKK | 441 | Q96JE7 | |
| LYRKSKALSDLGRYK | 126 | Q8IWR0 | |
| YAATKTKYRKRLDAA | 651 | Q49AG3 | |
| GSYAKVKSAYSERLK | 21 | Q9BXA7 | |
| LYRIFSKYGKVVKVT | 26 | Q8TBF4 | |
| RVKAVLKKREYGSKY | 111 | Q6PML9 | |
| LYIITKVRGYKTFLR | 106 | Q9BTW9 | |
| LLSVVFLATYYKRKR | 91 | Q6P9G4 | |
| EKYKSSRKLIDRAYK | 86 | A0A087WVF3 | |
| IITGLAYFLLSKRKK | 121 | A0PK05 | |
| VCKRKGYSYELKEII | 436 | P52735 | |
| EKEILFYRKTIGYKV | 786 | O60264 | |
| EKYKSSRKLIDRAYK | 86 | Q6DHY5 | |
| EKYKSSRKLIDRAYK | 86 | Q8IZP1 | |
| TRLTIKKYLDVKFEY | 246 | Q9NRD5 | |
| LGSSKTDLFYERKKY | 91 | Q7RTV0 | |
| GSYAKVKSAYSERLK | 21 | Q96PF2 | |
| GTTKSRKAYVRIAYL | 151 | O95185 | |
| EKYKSSRKLIDRAYK | 86 | A0A087X1G2 | |
| ADKLAGRTRKYKVIF | 101 | Q9H267 | |
| VLTLKKFKGDLAYRR | 21 | Q96EF9 | |
| EKYKSSRKLIDRAYK | 86 | A0A087WXS9 | |
| EKYKSSRKLIDRAYK | 86 | Q6IPX1 | |
| RLFITIYKDALKGKY | 1116 | Q7Z3T8 | |
| LKNDSLRKRYDGLKY | 186 | Q15631 | |
| KRKELLKYLTAASYL | 96 | Q15916 | |
| RKYDKEKVLLQLRYT | 961 | Q8NEV4 | |
| ILGYFIERKKKQSSR | 651 | Q00872 |